- Home
- STRO vs LODE Comparison
STRO vs LODE Comparison
Compare STRO & LODE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- LODE
- Stock Information
- Founded
- STRO 2003
- LODE 2008
- Country
- STRO United States
- LODE United States
- Employees
- STRO N/A
- LODE N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- LODE Major Chemicals
- Sector
- STRO Health Care
- LODE Industrials
- Exchange
- STRO Nasdaq
- LODE Nasdaq
- Market Cap
- STRO 69.1M
- LODE 74.6M
- IPO Year
- STRO 2018
- LODE N/A
- Fundamental
- Price
- STRO $0.97
- LODE $2.42
- Analyst Decision
- STRO Hold
- LODE Hold
- Analyst Count
- STRO 7
- LODE 1
- Target Price
- STRO $1.97
- LODE $4.00
- AVG Volume (30 Days)
- STRO 553.4K
- LODE 1.2M
- Earning Date
- STRO 08-07-2025
- LODE 10-21-2025
- Dividend Yield
- STRO N/A
- LODE N/A
- EPS Growth
- STRO N/A
- LODE N/A
- EPS
- STRO N/A
- LODE N/A
- Revenue
- STRO $104,473,000.00
- LODE $3,280,749.00
- Revenue This Year
- STRO $65.42
- LODE $16.44
- Revenue Next Year
- STRO N/A
- LODE $800.34
- P/E Ratio
- STRO N/A
- LODE N/A
- Revenue Growth
- STRO N/A
- LODE 58.55
- 52 Week Low
- STRO $0.52
- LODE $1.67
- 52 Week High
- STRO $4.80
- LODE $10.10
- Technical
- Relative Strength Index (RSI)
- STRO 58.41
- LODE 39.01
- Support Level
- STRO $0.90
- LODE $2.27
- Resistance Level
- STRO $1.18
- LODE $2.55
- Average True Range (ATR)
- STRO 0.09
- LODE 0.15
- MACD
- STRO 0.01
- LODE 0.04
- Stochastic Oscillator
- STRO 43.43
- LODE 40.91
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About LODE Comstock Inc.
Comstock Inc innovates and commercializes technologies that are deployable across entire industries to contribute to energy abundance by efficiently extracting and converting under-utilized natural resources, such as waste and other forms of woody biomass into renewable fuels, and end-of-life electronics into recovered electrification metals. Comstock's innovations group is engaged in developing and using artificial intelligence technologies for advanced materials development.